{"entity":{"type":"insider","cik":"0001344412","url":"/insider/0001344412","json_url":"/insider/0001344412.json","name":"Moretti August J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":59,"n_filings":15,"first":"2006-12-08","last":"2016-11-15","span_basis":"filed_date"},"name_variants":[{"name":"Moretti August J","source":"filing","n_filings":15,"first_seen":"2006-12-08","last_seen":"2016-11-15"}],"transactions":[{"id":2768913,"accession":"0001179110-16-031609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-16-031609","line_url":"/filing/0001179110-16-031609#line-2","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"DEPOMED INC","issuer_ticker":"DEPO","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (Chief Financial Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & SVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.84,"price_display":"20.84","price_state":"stated","total_value":104200.0,"total_display":"104,200.00","total_whole":"104,200","shares_owned_after":21680.0,"shares_owned_after_display":"21,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-15","scope":"insider"},{"id":2985230,"accession":"0001179110-16-028587","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-16-028587","line_url":"/filing/0001179110-16-028587","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"DEPOMED INC","issuer_ticker":"DEPO","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (Chief Financial Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & SVP","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":21.4,"price_display":"21.40","price_state":"stated","total_value":107000.0,"total_display":"107,000.00","total_whole":"107,000","shares_owned_after":21680.0,"shares_owned_after_display":"21,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-10","filed_date":"2016-08-11","scope":"insider","n_lines":2},{"id":2307276,"accession":"0001179110-16-024187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-024187","line_url":"/filing/0001179110-16-024187#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"DEPOMED INC","issuer_ticker":"DEPO","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (Chief Financial Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & SVP","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","total_whole":"90,000","shares_owned_after":22879.0,"shares_owned_after_display":"22,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-09","filed_date":"2016-05-09","scope":"insider"},{"id":8772690,"accession":"0001179110-15-015767","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-015767","line_url":"/filing/0001179110-15-015767","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"DEPOMED INC","issuer_ticker":"DEPO","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (Chief Financial Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & SVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":18.106499333333332,"price_display":"18.11","price_state":"stated","total_value":271597.49,"total_display":"271,597.49","total_whole":"271,597","shares_owned_after":23160.0,"shares_owned_after_display":"23,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-03","filed_date":"2015-12-03","scope":"insider","n_lines":2},{"id":6640201,"accession":"0001179110-14-017515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-017515","line_url":"/filing/0001179110-14-017515#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"DEPOMED INC","issuer_ticker":"DEPO","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5339.0,"shares_display":"5,339","price_per_share":15.853,"price_display":"15.85","price_state":"stated","total_value":84639.167,"total_display":"84,639.17","total_whole":"84,639","shares_owned_after":22564.0,"shares_owned_after_display":"22,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2014-12-03","scope":"insider"},{"id":4278160,"accession":"0001179110-13-017421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-017421","line_url":"/filing/0001179110-13-017421#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"DEPOMED INC","issuer_ticker":"DEPO","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2821.0,"shares_display":"2,821","price_per_share":8.4043,"price_display":"8.40","price_state":"stated","total_value":23708.5303,"total_display":"23,708.53","total_whole":"23,709","shares_owned_after":11214.0,"shares_owned_after_display":"11,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":7369703,"accession":"0001209191-10-026102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-026102","line_url":"/filing/0001209191-10-026102#line-2","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","total_whole":"35,000","shares_owned_after":43222.0,"shares_owned_after_display":"43,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-05","filed_date":"2010-05-07","scope":"insider"},{"id":9266906,"accession":"0001209191-09-058154","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-058154","line_url":"/filing/0001209191-09-058154#line-3","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7112.0,"shares_display":"7,112","price_per_share":2.1269,"price_display":"2.13","price_state":"stated","total_value":15126.5128,"total_display":"15,126.51","total_whole":"15,127","shares_owned_after":33183.0,"shares_owned_after_display":"33,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-18","filed_date":"2009-12-21","scope":"insider"},{"id":5935909,"accession":"0001209191-09-057998","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-057998","line_url":"/filing/0001209191-09-057998#line-3","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7117.0,"shares_display":"7,117","price_per_share":2.1269,"price_display":"2.13","price_state":"stated","total_value":15137.1473,"total_display":"15,137.15","total_whole":"15,137","shares_owned_after":33174.0,"shares_owned_after_display":"33,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-18","filed_date":"2009-12-18","scope":"insider"},{"id":9266905,"accession":"0001209191-09-058154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-058154","line_url":"/filing/0001209191-09-058154#line-2","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2456.0,"shares_display":"2,456","price_per_share":2.2007,"price_display":"2.20","price_state":"stated","total_value":5404.9192,"total_display":"5,404.92","total_whole":"5,405","shares_owned_after":40295.0,"shares_owned_after_display":"40,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-17","filed_date":"2009-12-21","scope":"insider"},{"id":5935908,"accession":"0001209191-09-057998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-057998","line_url":"/filing/0001209191-09-057998#line-2","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2457.0,"shares_display":"2,457","price_per_share":2.2007,"price_display":"2.20","price_state":"stated","total_value":5407.1199,"total_display":"5,407.12","total_whole":"5,407","shares_owned_after":40291.0,"shares_owned_after_display":"40,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-17","filed_date":"2009-12-18","scope":"insider"},{"id":9266904,"accession":"0001209191-09-058154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-058154","line_url":"/filing/0001209191-09-058154#line-1","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4432.0,"shares_display":"4,432","price_per_share":2.4071,"price_display":"2.41","price_state":"stated","total_value":10668.2672,"total_display":"10,668.27","total_whole":"10,668","shares_owned_after":42751.0,"shares_owned_after_display":"42,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-16","filed_date":"2009-12-21","scope":"insider"},{"id":5935906,"accession":"0001209191-09-057998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-057998","line_url":"/filing/0001209191-09-057998#line-1","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4435.0,"shares_display":"4,435","price_per_share":2.4071,"price_display":"2.41","price_state":"stated","total_value":10675.4885,"total_display":"10,675.49","total_whole":"10,675","shares_owned_after":42748.0,"shares_owned_after_display":"42,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-16","filed_date":"2009-12-18","scope":"insider"},{"id":3607801,"accession":"0001209191-08-021772","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-08-021772","line_url":"/filing/0001209191-08-021772","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":7.171448,"price_display":"7.17","price_state":"stated","total_value":35857.24,"total_display":"35,857.24","total_whole":"35,857","shares_owned_after":10474.0,"shares_owned_after_display":"10,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-01","filed_date":"2008-04-02","scope":"insider","n_lines":14},{"id":3966022,"accession":"0001209191-08-001034","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-08-001034","line_url":"/filing/0001209191-08-001034","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":7.8946,"price_display":"7.89","price_state":"stated","total_value":39473.0,"total_display":"39,473.00","total_whole":"39,473","shares_owned_after":12074.0,"shares_owned_after_display":"12,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-02","filed_date":"2008-01-03","scope":"insider","n_lines":16},{"id":8447839,"accession":"0001209191-07-056510","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-07-056510","line_url":"/filing/0001209191-07-056510#line-12","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":8.53,"price_display":"8.53","price_state":"stated","total_value":10236.0,"total_display":"10,236.00","total_whole":"10,236","shares_owned_after":9780.0,"shares_owned_after_display":"9,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-01","filed_date":"2007-10-03","scope":"insider"},{"id":8447835,"accession":"0001209191-07-056510","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-07-056510","line_url":"/filing/0001209191-07-056510#line-11","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":8.64,"price_display":"8.64","price_state":"stated","total_value":6048.0,"total_display":"6,048.00","total_whole":"6,048","shares_owned_after":8645.0,"shares_owned_after_display":"8,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-01","filed_date":"2007-10-03","scope":"insider"},{"id":8447830,"accession":"0001209191-07-056510","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-07-056510","line_url":"/filing/0001209191-07-056510#line-10","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":592.0,"shares_display":"592","price_per_share":8.52,"price_display":"8.52","price_state":"stated","total_value":5043.84,"total_display":"5,043.84","total_whole":"5,044","shares_owned_after":10980.0,"shares_owned_after_display":"10,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-01","filed_date":"2007-10-03","scope":"insider"},{"id":8447822,"accession":"0001209191-07-056510","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-07-056510","line_url":"/filing/0001209191-07-056510#line-9","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":8.66,"price_display":"8.66","price_state":"stated","total_value":4330.0,"total_display":"4,330.00","total_whole":"4,330","shares_owned_after":7837.0,"shares_owned_after_display":"7,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-01","filed_date":"2007-10-03","scope":"insider"},{"id":8447816,"accession":"0001209191-07-056510","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-07-056510","line_url":"/filing/0001209191-07-056510#line-8","is_derivative":false,"issuer_cik":"0001344412","issuer_name":"Alexza Pharmaceuticals Inc.","issuer_ticker":"ALXA","issuer_name_source":null,"issuer_url":"/issuer/0001344412","owner_cik":"0001344412","owner_name":"Moretti August J","owner_display_name":"Moretti August J","owner_url":"/insider/0001344412","role":"Officer (SVP, CFO & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":448.0,"shares_display":"448","price_per_share":8.51,"price_display":"8.51","price_state":"stated","total_value":3812.48,"total_display":"3,812.48","total_whole":"3,812","shares_owned_after":11572.0,"shares_owned_after_display":"11,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-01","filed_date":"2007-10-03","scope":"insider"}],"collapsed":true,"next_cursor":"2007-10-01|8447816","ledger_fault":false,"count":{"value":59,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":59,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":59},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001005201","name":"DEPOMED INC","url":"/issuer/0001005201","role":"Officer (Chief Financial Officer & SVP)","n_filings":6,"first_seen":"2013-12-04","last_seen":"2016-11-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001344413","name":"Alexza Pharmaceuticals Inc.","url":"/issuer/0001344413","role":"Officer (SVP, CFO & Sec)","n_filings":9,"first_seen":"2006-12-08","last_seen":"2010-05-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001344412","retrieved_at":"2026-08-26T13:56:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}